Approach to the Patient: Diagnosis of Cushing Syndrome.
Savas M, Mehta S, Agrawal N, van Rossum EFC, Feelders RA.
J Clin Endocrinol Metab. 2022 Nov 23;107(11):3162-3174. doi: 10.1210/clinem/dgac492.
PMID:36036941
Pseudo-Cushing's States.
Androulakis II, Kaltsas G, Chrousos G.
2015 May 8. In: Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.
PMID:25905307
Case report: Pheochromocytoma-induced pseudo-Cushing's syndrome.
Bobrowicz M, Nagórska A, Karpiłowska A, Rosłon M, Hubska J, Gładka A, Toutounchi S, Koperski Ł, Ambroziak U.
Front Endocrinol (Lausanne). 2024 Dec 16;15:1491873. doi: 10.3389/fendo.2024.1491873. eCollection 2024.
PMID:39741882
The difficulties of pseudo-Cushing's syndrome (or "non-neoplastic hypercortisolism").
Lancet. 1993 Mar 13;341(8846):676-7. doi: 10.1016/0140-6736(93)90434-i.
PMID:8095582
[Pseudo-Cushing syndrome. Physiopathologic aspects and differential diagnosis].
Ceroni L, Cota D, Pasquali R.
Minerva Endocrinol. 2000 Jun;25(2):47-54.
PMID:11189791
Hypercortisolism (Cushing Syndrome).
John TA, Anastasopoulou C.
2025 Nov 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
PMID:31855370
DIAGNOSIS OF ENDOCRINE DISEASE: Differentiation of pathologic/neoplastic hypercortisolism (Cushing's syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome).